Piramal Pharma Limited (NSE:PPLPHARMA)
India flag India · Delayed Price · Currency is INR
190.04
-2.09 (-1.09%)
Aug 14, 2025, 3:30 PM IST

Piramal Pharma Company Description

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.

The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network.

It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene, as well as adult incontinence.

The company was incorporated in 2020 and is based in Mumbai, India.

Piramal Pharma Limited
Country India
Founded 2020
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 5,476

Contact Details

Address:
Piramal Ananta
Mumbai, Maharashtra 400 070
India
Phone 91 22 3802 3000
Website piramalpharma.com

Stock Details

Ticker Symbol PPLPHARMA
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE0DK501011
SIC Code 2834

Key Executives

Name Position
Peter Daniel DeYoung Chief Executive Officer of Piramal Global Pharma and Director
Nandini Ajay Piramal Executive Chairperson
Vivek Valsaraj Chief Financial Officer and Executive Director
Vinay Agarwal Senior Vice President of Operations
Viral Gandhi President and Group CIO of Piramal Group
Gagan Borana Head of Investor Relations and Sustainability
Tanya Sanish Company Secretary and Compliance Officer
Sandeep K. Rathod General Counsel
Prashanth M. S. Vice President of Sales
Puneet Rajput Chief Human Resources Officer